Gene · 7337
Papers4,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Update on techniques for cryopreservation of human spermatozoa. | Asian J Androl | 2022 | 35381695 | PubTator, text mining | PubMed |
| Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention. | Mol Diagn Ther | 2022 | 35380358 | PubTator, text mining | PubMed |
| Genomic Imprinting in the New Omics Era: A Model for Systems-Level Approaches. | Front Genet | 2022 | 35368671 | PubTator, text mining | PubMed |
| The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors. | Cell Death Dis | 2022 | 35368029 | PubTator, text mining | PubMed |
| Novel multilocus imprinting disturbances in a child with expressive language delay and intellectual disability. | Am J Med Genet A | 2022 | 35365979 | PubTator, text mining | PubMed |
| Deciphering the mechanisms of HPV E6 mutations in the destabilization of E6/E6AP/p53 complex. | Biophys J | 2022 | 35364103 | PubTator, text mining | PubMed |
| Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C. | Front Immunol | 2022 | 35360001 | PubTator, text mining | PubMed |
| Modeling Epilepsy Using Human Induced Pluripotent Stem Cells-Derived Neuronal Cultures Carrying Mutations in Ion Channels and the Mechanistic Target of Rapamycin Pathway. | Front Mol Neurosci | 2022 | 35359577 | PubTator, text mining | PubMed |
| Mammalian Ddi2 is a shuttling factor containing a retroviral protease domain that influences binding of ubiquitylated proteins and proteasomal degradation. | J Biol Chem | 2022 | 35358511 | PubTator, text mining | PubMed |
| Comprehensive characterization of human-virus protein-protein interactions reveals disease comorbidities and potential antiviral drugs. | Comput Struct Biotechnol J | 2022 | 35356543 | PubTator, text mining | PubMed |
| X Chromosome Inactivation Timing is Not eXACT: Implications for Autism Spectrum Disorders. | Front Genet | 2022 | 35356429 | PubTator, text mining | PubMed |
| NEDD4 attenuates phosgene-induced acute lung injury through the inhibition of Notch1 activation. | J Cell Mol Med | 2022 | 35355403 | PubTator, text mining | PubMed |
| Viral and Clinical Oncology of Head and Neck Cancers. | Curr Oncol Rep | 2022 | 35347592 | PubTator, text mining | PubMed |
| Generation and characterization of induced pluripotent stem cell line (IBBISTi004-A) from an Angelman syndrome patient carrying a class II deletion of the maternal chromosome 15q11.2-q13. | Stem Cell Res | 2022 | 35339881 | PubTator, text mining | PubMed |
| A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects. | Molecules | 2022 | 35335337 | PubTator, text mining | PubMed |
| Non-human primate papillomavirus E6-mediated p53 degradation reveals ancient evolutionary adaptation of carcinogenic phenotype to host niche. | PLoS Pathog | 2022 | 35333912 | PubTator, text mining | PubMed |
| Oxidative stress-induced circKIF18A downregulation impairs MCM7-mediated anti-senescence in intervertebral disc degeneration. | Exp Mol Med | 2022 | 35332256 | PubTator, text mining | PubMed |
| Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road. | Biomolecules | 2022 | 35327659 | PubTator, text mining | PubMed |
| Disruption of the Ubiquitin-Proteasome System and Elevated Endoplasmic Reticulum Stress in Epilepsy. | Biomedicines | 2022 | 35327449 | PubTator, text mining | PubMed |
| Human papillomavirus type 16 E6 induces cell competition. | PLoS Pathog | 2022 | 35320322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/papers?page=43